OS of over 20 months? Doesn’t this seem very unlikely?
OS of over 20 months? Doesn’t this seem very unlikely? I’d expect maybe a few reaching 15 months. I hope that’s true but that would pretty bizarre leap in care especially since these were very progressive cases of cancer.
36 months would lead us to believe we basically cured cancer at this point? Maybe this is why the data is urgent?
I don’t want to get my hopes up, but once again ohm is this actually possible? Obviously nobody can really answer that without the data but this just seems too good to be true.
“Come 9/16/2022, we should be able to learn what the more refined PFS is for these 21 patients and what the more refined Overall Survivability is for these 21 patients. The study started 4/22/2019. By 7/19/21, the PFS was 8 months and the OS was 36 months. Since then, 13 months have passed. All in All, the patients were not very healthy. It was a combination of Compassionate Use, brain metastasis and patients had failed 2 other treatment protocols. Patients were treated differently, and may only have received up to 4 doses of leronlimab + carboplatin total while some other received much more, however, leronlimab may have been dosed even after PFS endpoint was reached and after the cancer had returned which may have extended OS. Hopefully, all of this is documented in the results of the trial. From the 7/19/21 PR above, we currently had a PFS of 8 months and an OS of 36 months. Since November 2021, the PFS was recalculated to be 6.5 months and the OS became 12.5 months. 10 months have passed since then. Come 9/16/22, could the OS go to 20+ months?”
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Delta's Commitment to Global Sustainability Delta's name pops up yet again at the United Nations Climate Change Conference (COP31) in Antalya, Turkey, marking the company's 19th consecutive year of participation. They're mounting efforts to hit that "35×35" target, aiming for 35% electrification by 2035. This isn't just fluff and rhetoric—it’s Delta taking the lead...
Continue Reading
Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...
Continue Reading
Lululemon in Legal Crosshairs So, here's the scoop that's rocking the activewear world. Lululemon athletica inc. (NASDAQ: LULU) is finding itself in hot legal water. The DJS Law Group is sounding the alarm for investors following a securities violation lawsuit slapped on the company. We're talking about some heavy allegations of misleading maneuvers, with accusations...
Continue Reading
TURNSON Raises the Bar for Social Fun When was the last time a new drinking game actually turned heads? Well, meet TURNSON, the fresh contender coming out of a tiny town in Louisiana. Thanks to a couple of inventive minds, this game aims to redefine how adults bond at parties. It's got the ingredients to stir up some excitement at social gatherings, parties, and wherever...
Continue Reading
Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...
Continue Reading
The Rise of Spatial Genomics You’ve got to hand it to the science behind spatial genomics and transcriptomics—this arena’s not just on a hot streak; it’s scorching. We’re staring down the barrel of a market raring to more than double in value, surging from a worth of USD 0.67 billion in 2026 straight to the big USD 1.23 billion in 2031. The CAGR that’s...
Continue Reading
Nutex Health: Accolades and Aspirations Nutex Health just snagged something pretty noteworthy: They've been crowned a 2026 Houston Top Workplace by the Houston Chronicle. Now, before you start throwing confetti, let's chew on what this really means. It's no small potatoes, folks. We're talking employee respect and satisfaction measured by Energage’s surveys. It's proof...
Continue Reading
AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...
Continue Reading
California Credit Union Joins Forces for Holiday Toy Drive Alright, folks, here’s a story with a feel-good spin straight out of Glendale. California Credit Union is at it again, teaming up with the Los Angeles Boys & Girls Club to sprinkle some holiday magic on local kiddos and their families. Now, it’s the sixth year straight they’ve pulled off this toy drive...
Continue Reading
If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...
Continue Reading
Top 5 Most Recently Viewed Articles
Exciting Developments from Lyell Immunopharma In a recent presentation at a major medical conference, Lyell Immunopharma, Inc. (NASDAQ: LYEL), showcased groundbreaking clinical data surrounding its innovative cancer therapy candidate, ronde-cel, designed specifically for patients suffering from large B-cell lymphoma (LBCL). Their findings reveal high rates of durable...
Continue Reading
United Imaging Healthcare Embraces New Leadership United Imaging, a global leader in advanced medical imaging and radiotherapy solutions, is thrilled to announce that John Campbell has joined the team as the Vice President of Customer Success for North America. In this strategic role, Campbell will play a vital part in nurturing customer partnerships, driving service...
Continue Reading
Empowering Developers with New AIoT Technology Engines At the recent TUYA Global Developer Summit, Tuya Smart showcased its groundbreaking contributions to the Artificial Intelligence of Things (AIoT). This event marked an important milestone as Tuya introduced not just one, but four advanced technology engines designed specifically for developers. These engines are set...
Continue Reading
Recent Decline in Sui Cryptocurrency's Value In the latest financial update, the cryptocurrency Sui has seen a decline of 4.87% within the last 24 hours, bringing its price down to $1.93. This downward trajectory has been consistent over the previous week as well, where Sui recorded a 10% loss, dropping from $2.09 to its current value. Such fluctuations are common in the...
Continue Reading
Komatsu Projects Record Sales Despite Industry Challenges In a recent earnings call, Komatsu Ltd (OTC: KMTUY), a leading global player in construction and mining equipment, presented its mixed financial results for the second quarter of fiscal 2024. The company reported a commendable year-on-year increase in net sales by 9.2%, amounting to JPY 1.082 trillion, marking a...
Continue Reading